By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BGI and the Asia Cancer Research Group today announced a collaboration to develop a genomic data source on cancers prevalent in Asia.

The partners will conduct research on lung cancer and liver cancer, two of the most common cancers in Asia, in the hopes of ultimately developing treatments.

ACRG will provide lung and liver cancer samples, which BGI will sequence. In addition to producing data, BGI will provide bioinformatics analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.